학술논문

Inhibition of IL1 beta by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial
Document Type
Journal
Source
CANCER RESEARCH; DEC 15 2020, 80 24, p5597-p5605, 9p.
Subject
Language
English
ISSN
15387445